These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11754629)

  • 1. A recently developed typhoid Vi polysaccharide vaccine: rationale and clinical profile.
    Zuckerman JN
    BioDrugs; 2001; 15 Suppl 1():1-4. PubMed ID: 11754629
    [No Abstract]   [Full Text] [Related]  

  • 2. Population impact of Vi capsular polysaccharide vaccine.
    Khan MI; Ochiai RL; Clemens JD
    Expert Rev Vaccines; 2010 May; 9(5):485-96. PubMed ID: 20450323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines.
    Zuckerman JN; Hatz C; Kantele A
    Expert Rev Vaccines; 2017 Oct; 16(10):1029-1043. PubMed ID: 28856924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Field effectiveness of Vi polysaccharide typhoid vaccine in the People's Republic of China.
    Arya SC
    J Infect Dis; 2002 Mar; 185(6):845; author reply 845-6. PubMed ID: 11920305
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of Vi polysaccharide vaccine against Salmonella typhi.
    Arya SC
    Vaccine; 1999 Mar; 17(9-10):1015-6. PubMed ID: 10195609
    [No Abstract]   [Full Text] [Related]  

  • 6. An outbreak of typhoid fever, Xing-An County, People's Republic of China, 1999: estimation of the field effectiveness of Vi polysaccharide typhoid vaccine.
    Yang HH; Kilgore PE; Yang LH; Park JK; Pan YF; Kim Y; Lee YJ; Xu ZY; Clemens JD
    J Infect Dis; 2001 Jun; 183(12):1775-80. PubMed ID: 11372030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Typhoid vaccines.
    Wkly Epidemiol Rec; 2000 Aug; 75(32):257-64. PubMed ID: 10974947
    [No Abstract]   [Full Text] [Related]  

  • 8. Current concepts in the diagnosis and treatment of typhoid fever.
    Bhutta ZA
    BMJ; 2006 Jul; 333(7558):78-82. PubMed ID: 16825230
    [No Abstract]   [Full Text] [Related]  

  • 9. Extensively Drug-Resistant Typhoid - Are Conjugate Vaccines Arriving Just in Time?
    Andrews JR; Qamar FN; Charles RC; Ryan ET
    N Engl J Med; 2018 Oct; 379(16):1493-1495. PubMed ID: 30332569
    [No Abstract]   [Full Text] [Related]  

  • 10. Vi polysaccharide-protein conjugate vaccine for the prevention of typhoid fever in children: hope or hype?
    Pulickal AS; Pollard AJ
    Expert Rev Vaccines; 2007 Jun; 6(3):293-5. PubMed ID: 17542742
    [No Abstract]   [Full Text] [Related]  

  • 11. Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: a cluster randomized trial in Karachi, Pakistan.
    Khan MI; Soofi SB; Ochiai RL; Habib MA; Sahito SM; Nizami SQ; Acosta CJ; Clemens JD; Bhutta ZA;
    Vaccine; 2012 Aug; 30(36):5389-95. PubMed ID: 22721899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Typhoid vaccination: the Asian experience.
    DeRoeck D; Ochiai RL; Yang J; Anh DD; Alag V; Clemens JD
    Expert Rev Vaccines; 2008 Jul; 7(5):547-60. PubMed ID: 18564010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Japanese study to assess immunogenicity and safety of a typhoid Vi polysaccharide vaccine.
    Miyazu M; Kikuchi H; Hamada A; Fukushima S; Ouchi K; Bosch Castells V; Mihara H; Bonnet MC
    Vaccine; 2015 Nov; 33(48):6697-702. PubMed ID: 26518404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.
    Arya SC; Agarwal N
    N Engl J Med; 2009 Nov; 361(22):2191; author reply 2192-3. PubMed ID: 19940305
    [No Abstract]   [Full Text] [Related]  

  • 15. Typhoid and paratyphoid fever.
    Basnyat B
    Lancet; 2005 Nov; 366(9497):1603. PubMed ID: 16271636
    [No Abstract]   [Full Text] [Related]  

  • 16. Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae.
    Pakkanen SH; Kantele JM; Herzog C; Kantele A
    Vaccine; 2014 Jan; 32(5):544-51. PubMed ID: 24342246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.
    Sur D; Ochiai RL; Bhattacharya SK; Ganguly NK; Ali M; Manna B; Dutta S; Donner A; Kanungo S; Park JK; Puri MK; Kim DR; Dutta D; Bhaduri B; Acosta CJ; Clemens JD
    N Engl J Med; 2009 Jul; 361(4):335-44. PubMed ID: 19625715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statement on overseas travellers and typhoid fever.
    CMAJ; 1994 Oct; 151(7):989-92. PubMed ID: 7922935
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of epidemiology in the introduction of vi polysaccharide typhoid fever vaccines in Asia.
    Acosta CJ; Galindo CM; Ochiai RL; Danovaro-Holliday MC; Page AL; Thiem VD; Park JK; Park E; Koo H; Wang XY; Abu-Elyazeed R; Ali M; Albert MJ; Ivanoff B; Pang T; Xu ZY; Clemens JD
    J Health Popul Nutr; 2004 Sep; 22(3):240-5. PubMed ID: 15609776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reassessment of frequency of occurrence of typhoid fever and cost efficacy analysis of antibiotic therapy.
    Sridhar CB; Kulkarni RD
    J Assoc Physicians India; 1995 Oct; 43(10):679-84. PubMed ID: 8773003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.